Regenxbio (RGNX) EBT Margin Growth (5y) (2019 - 2025)
Regenxbio (RGNX) EBT Margin Growth (5y) (2019 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
Regenxbio |
325.94 Mn |
95.87 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
-52,666.00 |
| Sep 30, 2025 |
-21,727.00 |
| Jun 30, 2025 |
-12,509.00 |
| Mar 31, 2025 |
23,373.00 |
| Dec 31, 2024 |
-82,444.00 |
| Sep 30, 2024 |
-1,001.00 |
| Jun 30, 2024 |
-21,768.00 |
| Mar 31, 2024 |
324,799.00 |
| Dec 31, 2023 |
-29,817.00 |
| Sep 30, 2023 |
17,227.00 |
| Jun 30, 2023 |
-39,680.00 |
| Mar 31, 2023 |
-42,713.00 |
| Dec 31, 2022 |
148,567.00 |
| Sep 30, 2022 |
126,513.00 |
| Jun 30, 2022 |
1,173.00 |
| Mar 31, 2022 |
448,812.00 |
| Dec 31, 2021 |
125,890.00 |
| Sep 30, 2021 |
1.43 Mn |
| Jun 30, 2021 |
34,629.00 |
| Mar 31, 2021 |
247,446.00 |
